Home

ARTHUR PRZYBYL

CIK 1268135 · President and CEO · last filed 2020-04-08

ARTHUR PRZYBYL is a President and CEO who has filed 71 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $234.8K of ANIP on Apr 8, 2020. Across all open-market trades the lifetime net is −$15.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.24M

Companies

5

Total Filings

71

Lifetime Open-Market Net

-$15.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANIP President and CEO 192,424 $79.20 $15.24M -$4.60M 42 2020-04-08
ANI PHARMACEUTICALS INC (FOLD) Delisted President and CEO 202,589 $14.49 $2.94M -$10.31M 19 2019-05-15
ANI PHARMACEUTICALS INC (BPAX) Delisted President and CEO 327,748 — — $0 2 2013-07-16
AKORN INC (AKRX) Delisted President, CEO 850,445 — — -$930.2K 7 2009-01-02
AKORN INC (AKN) Delisted President, CEO — — — $0 1 2007-01-04

Recent Filings

71 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-04-08 ANIP Tax (F) −5,397 -$234.8K EDGAR
2020-03-31 ANIP Tax (F) −6,883 -$267.9K EDGAR
2019-05-15 ANI PHARMACEUTICALS INC (FOLD) Delisted Sell (S) −30,000 -$2.10M EDGAR
2019-04-18 ANI PHARMACEUTICALS INC (FOLD) Delisted Tax (F) −1,692 -$116.1K EDGAR
2019-04-09 ANI PHARMACEUTICALS INC (FOLD) Delisted Tax (F) −5,397 -$380.5K EDGAR
2019-04-02 ANI PHARMACEUTICALS INC (FOLD) Delisted Tax (F) −2,678 -$188.9K EDGAR
2019-04-01 ANI PHARMACEUTICALS INC (FOLD) Delisted Grant (A) +37,280 $0 EDGAR
2019-03-20 ANI PHARMACEUTICALS INC (FOLD) Delisted Mixed −27,625 -$1.75M EDGAR
2018-05-24 ANI PHARMACEUTICALS INC (FOLD) Delisted Tax (F) −1,375 -$85.1K EDGAR
2018-04-18 ANI PHARMACEUTICALS INC (FOLD) Delisted Tax (F) −1,611 -$97.0K EDGAR
Showing 1–10 of 71
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.